Zobrazeno 1 - 10
of 112
pro vyhledávání: '"Daijiro Harada"'
Autor:
Hisako Ichihara, Manabu Yamada, Mitsuyo Kohara, Hideki Hirakawa, Andrea Ghelfi, Takuro Tamura, Akihiro Nakaya, Yasukazu Nakamura, Sachiko Shirasawa, Samatchaya Yamashita, Yosuke Toda, Daijiro Harada, Tsunakazu Fujishiro, Akiko Komaki, Jeffrey A. Fawcett, Eiji Sugihara, Satoshi Tabata, Sachiko N. Isobe
Publikováno v:
BMC Plant Biology, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Plant genome information is fundamental to plant research and development. Along with the increase in the number of published plant genomes, there is a need for an efficient system to retrieve various kinds of genome-related infor
Externí odkaz:
https://doaj.org/article/948115dfd5d348bf8dfcfb634bdc59b6
Autor:
Daijiro Harada, Tomoki Tamura, Kiichiro Ninomiya, Toshio Kubo, Shoichi Kuyama, Sayaka Tachibana, Koji Inoue, Kenichi Chikamori, Kenichiro Kudo, Nobuaki Ochi, Yoshinobu Maeda, Katsuyuki Kiura
Publikováno v:
Thoracic Cancer, Vol 14, Iss 3, Pp 231-236 (2023)
Abstract Background COVID‐19 incidence is high in patients with cancer. The fatality rate was high for the Delta variant, necessitating infection prevention by vaccination. This study evaluated the safety of a SARS‐CoV‐2 vaccine in patients wit
Externí odkaz:
https://doaj.org/article/97bb7b8b8c774c5ea9342c7b835db576
Autor:
Tomoki Tamura, Kiichiro Ninomiya, Toshio Kubo, Shoichi Kuyama, Sayaka Tachibana, Koji Inoue, Kenichi Chikamori, Kenichiro Kudo, Nobuaki Ochi, Daijiro Harada, Yoshinobu Maeda, Katsuyuki Kiura
Publikováno v:
Thoracic Cancer, Vol 13, Iss 3, Pp 453-459 (2022)
Abstract Background Since 2020, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has become prevalent worldwide. In severe cases, the case fatality rate is high, and vaccine prevention is important. This study evaluated the safety of
Externí odkaz:
https://doaj.org/article/424ceb059e7e4c87aac9877f602b5941
Autor:
Naoko Sueoka‐Aragane, Chiho Nakashima, Hironori Yoshida, Naohisa Matsumoto, Kentaro Iwanaga, Noriyuki Ebi, Akihiro Nishiyama, Kazuhiro Yatera, Shoichi Kuyama, Minoru Fukuda, Sunao Ushijima, Hitomi Umeguchi, Daijiro Harada, Kosuke Kashiwabara, Takayuki Suetsugu, Nobukazu Fujimoto, Fumihiro Tanaka, Hidetaka Uramoto, Chiharu Yoshii, Katsumi Nakatomi, Genju Koh, Nobuhiko Seki, Keisuke Aoe, Kaname Nosaki, Koji Inoue, Ayako Takamori, Atsushi Kawaguchi
Publikováno v:
Cancer Medicine, Vol 10, Iss 12, Pp 3873-3885 (2021)
Abstract Background EGFR mutations are good predictive markers of efficacy of EGFR tyrosine kinase inhibitors (EGFR‐TKI), but whether comprehensive genomic analysis beyond EGFR itself with circulating tumor DNA (ctDNA) adds further predictive or pr
Externí odkaz:
https://doaj.org/article/9fdb0934bf3d40bbb7a19d2b98a77955
Autor:
Daijiro Harada, Hideko Isozaki, Toshiyuki Kozuki, Toshihide Yokoyama, Hiroshige Yoshioka, Akihiro Bessho, Shinobu Hosokawa, Ichiro Takata, Nagio Takigawa, Katsuyuki Hotta, Katsuyuki Kiura, Okayama Lung Cancer Study Group
Publikováno v:
Thoracic Cancer, Vol 12, Iss 5, Pp 643-649 (2021)
Abstract Background The efficacy of crizotinib treatment for recurring EML4‐ALK‐positive non‐small cell lung cancer (NSCLC) previously treated with alectinib is unclear. Based on our preclinical findings regarding hepatocyte growth factor/mesen
Externí odkaz:
https://doaj.org/article/969d0f50286c4d95ae3bc781ec7bc518
Autor:
Tsuneo Shimokawa, Kazuhiko Yamada, Hiroshi Tanaka, Kaoru Kubota, Yuichi Takiguchi, Kazuma Kishi, Haruhiro Saito, Yukio Hosomi, Terufumi Kato, Daijiro Harada, Sakiko Otani, Takashi Kasai, Yoichi Nakamura, Toshihiro Misumi, Takeharu Yamanaka, Hiroaki Okamoto
Publikováno v:
Cancer Medicine, Vol 10, Iss 2, Pp 626-633 (2021)
Abstract Cisplatin‐based chemoradiotherapy is considered standard treatment for unresectable locally advanced non‐small‐cell lung cancer (LA‐NSCLC). This study examined two regimens of chemotherapy in concurrent chemoradiation. Eligible patie
Externí odkaz:
https://doaj.org/article/dc1eba30fc41412aae54e7ba335364a6
Autor:
Nobukazu Fujimoto, Yosuke Miyamoto, Sae Wada, Katsuyuki Hotta, Toshiyuki Kozuki, Keisuke Aoe, Jun Sakurai, Michihiro Yoshida, Daijiro Harada
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021)
Externí odkaz:
https://doaj.org/article/af8197ea96ff4fda8b8b228a37b81135
Autor:
Daijiro Harada, Nagio Takigawa
Publikováno v:
Cancers, Vol 13, Iss 22, p 5823 (2021)
We reviewed the literature on oligoprogressive disease (OPD) and local ablative therapy (LAT) in patients with advanced non-small cell lung cancer (NSCLC). The frequency of OPD varies depending on its definition and is estimated to be between 15–47
Externí odkaz:
https://doaj.org/article/8a9c547006e546d2b1c06ebecb252fe7
Publikováno v:
Cancers, Vol 6, Iss 2, Pp 708-722 (2014)
Persistent phosphorylation of signal transducer and activator of transcription 3 (STAT3) has been demonstrated in 22%~65% of non-small cell lung cancers (NSCLC). STAT3 activation is mediated by receptor tyrosine kinases, such as epidermal growth fact
Externí odkaz:
https://doaj.org/article/6289ec44138644ae98eb97c26dd27c0f
Autor:
Daijiro Harada, Tomoki Tamura, Kiichiro Ninomiya, Toshio Kubo, Shoichi Kuyama, Sayaka Tachibana, Koji Inoue, Kenichi Chikamori, Kenichiro Kudo, Nobuaki Ochi, Yoshinobu Maeda, Katsuyuki Kiura
Publikováno v:
Thoracic Cancer. 14:231-236